HistoSonics Announces $100 Million in Financings and New Appointment to its Board of Directors

Financings Planned to Support Rapid Expansion of Histotripsy Platform as Company Welcomes Silk Road Medical CEO, Erica Rogers, to its Board of Directors MINNEAPOLIS, Dec. 13, 2022 /PRNewswire/ — HistoSonics, Inc. (www.histosonics.com), the developer of a non-invasive, novel sonic beam…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.